Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medicus Pharma Ltd. Regulatory Filings 2024

Nov 16, 2024

34562_ffr_2024-11-18_790f3d04-e7c9-4c12-a98e-bdfc335c3035.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

6-K 1 form6k.htm FORM 6-K Medicus Pharma Ltd.: Form 6-K - Filed by newsfilecorp.com

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of November 2024 .

Commission File Number 001-42408

MEDICUS PHARMA LTD. (Translation of registrant's name into English)

Suite 3400, 100 King St W

Toronto, Ontario, Canada

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Equinox Gold Corp. — /s/ Raza Bokhari
Name: Dr. Raza Bokhari
Title: Executive Chairman and Chief Executive Officer

INDEX TO EXHIBITS

Exhibit Description
99.1 Press release, dated November 13, 2024
99.2 Press release, dated November 15, 2024
99.3 Warrant Agency Agreement, dated November 15, 2024
99.4 Common Share Purchase Warrant